Nikebio’s core strength lies in proprietary mammalian cell culture and recombinant expression platforms. These platforms employ several proprietary reagents that are specially optimized to enhance the expression levels of recombinant antibody in 293 and CHO cells.

We provide a variety of packages for customers who require recombinant antibody production services. Recombinant antibodies can be produced in a wide range of formats, including full-length, scFv, Fab, sdAb/VHH, Fc fusion protein, chimeric, and bispecific antibodies.

Starting with antibody (or VH/VL) sequence information, hybridoma cells, or cDNA, Nikebio can deliver high-quality recombinant antibodies with high purity and low endotoxin levels, along with detailed project reports containing detailed QC data.